CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the Commercialization of its Inhalation Products.

Food and Healthcare Press Releases Thursday July 2, 2020 09:40
SUZHOU China--2 Jul--PRNewswire/InfoQuest

CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in total, successfully completing an equity investment deal of nearly US $140M within six months. The investors participated in the Series F financing include BioTrack Capital, CICC Qichen, CICC Qide, SAIC Hengxu, GP M&A Fund and Watson Investment. Its existing investors including Passion Capital and Yuanming Capital also participated. CEC Capital served as CF PharmTech's exclusive financial advisor for both Series E and F financing.

There are nearly 300 million people suffering from asthma, chronic obstructive pulmonary disease (COPD) or rhinitis in China. The occurrence of these chronic diseases continues to rise. The State Council's Opinions on the Implementation of Healthy China Actions issued by the State Council in July 2019 defined COPD in China as a major chronic disease that seriously affects quality of life, along with cancers, cardiovascular disease and diabetes. With this new round of funding, CF Pharmtech is more poised than ever to provide respiratory disease treatments for China and global market.

About CF PharmTech:

CF PharmTech is a fully integrated specialty pharmaceutical company dedicated to providing affordable and high-quality respiratory drugs globally.   Managed by a high caliber team with extensive experience in the industry, the company focuses on the development of drugs for the treatment of respiratory diseases in its state-of-the-art facilities. Learn more about CF PharmTech, visit

Photo -
Caption: CF PharmTech’s manufacturing facility

Latest Press Release

How Protein Can Help You Resist Unhealthy Holiday Temptations

By: Susan Bowerman, M.S.,RD,CSSD, CSOWM, FAND – Sr.Director, Worldwide Nutrition Education and Training, Herbalife Nutrition The holidays are a time to be around friends, family,and of course, food. But many of our holiday treats and dishes can...

Caprion-HistoGeneX and Viroclinics-DDL announce a strategic partnership to offer integrated, complementary services to advance infectious disease research and COVID-19 therapeutic development

Caprion-HistoGeneX, a specialized CRO providing immunology, proteomics, histopathology and genomics services, and Viroclinics-DDL, a provider of preclinical and clinical trial services for vaccine, antiviral, and diagnostic development, are pleased to...

Theptarin Hospital and Chatrium Hotel Riverside Bangkok introduce the 'Sleepless Society Program’ based on the Meditel concept

Meditel is a sensational development in the healthcare field, where people can receive exceptional services without going to hospital, and Chatrium Hotel Riverside Bangkok is in an excellent position to support these healthcare advances. Additionally,...


สมาคม American Lighting Association, National Electrical Manufacturers Association และ UL ได้ออกเอกสารแสดงจุดยืนฉบับใหม่ หวังผลักดันความเสี่ยงในการใช้แสง UVC...

Lighting Industry Leaders Join Forces to Offer Ultraviolet Light Safety Guidance

American Lighting Association, the National Electrical Manufacturers Association and UL bring UVC light application risks to the forefront with new position paper With a shared commitment to the safety and performance of electrical lighting, UL, a...

Related Topics